GSK to sell oncology arm to Novartis

British pharmaceutical giant GlaxoSmithKline is to sell its oncology business to peer Novartis for US$16 billion and to buy the Swiss company's vaccin...



via The Standard - Breaking News http://ift.tt/1eYOU9a